 | • レポートコード：MRC2-11QY00945 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、183ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は皮膚糸状菌性爪真菌症のグローバル市場について調査・分析したレポートです。種類別（経口、局所）市場規模、用途別（病院、診療所・研究所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別皮膚糸状菌性爪真菌症の競争状況、市場シェア ・世界の皮膚糸状菌性爪真菌症市場：種類別市場規模 2015年-2020年（経口、局所） ・世界の皮膚糸状菌性爪真菌症市場：種類別市場規模予測 2021年-2026年（経口、局所） ・世界の皮膚糸状菌性爪真菌症市場：用途別市場規模 2015年-2020年（病院、診療所・研究所、その他） ・世界の皮膚糸状菌性爪真菌症市場：用途別市場規模予測 2021年-2026年（病院、診療所・研究所、その他） ・北米の皮膚糸状菌性爪真菌症市場分析：米国、カナダ ・ヨーロッパの皮膚糸状菌性爪真菌症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの皮膚糸状菌性爪真菌症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の皮膚糸状菌性爪真菌症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの皮膚糸状菌性爪真菌症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Anacor Pharmaceuticals、Galderma、Janssen Biotech、Novartis、Bausch Health、Abeona Therapeutics、Allergan、Elorac、GlaxoSmithKline、Hexima、Hisamitsu Pharmaceutical、Mayne Pharma、MediQuest Therapeutics、Meiji Seika Pharma、Merz Pharma、Moberg Pharma、NanoBio、NovaBiotics、Nuvo Research、Pfizer、Polichem、Promius Pharma、Sanofi、Seren Pharmaceuticals、Taro Pharmaceutical、Topica Pharmaceuticals、Viamet Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
Market Analysis and Insights: Global Dermatophytic Onychomycosis Market
The global Dermatophytic Onychomycosis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Dermatophytic Onychomycosis Scope and Market Size
Dermatophytic Onychomycosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dermatophytic Onychomycosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Dermatophytic Onychomycosis market is segmented into
Oral
Topical
Segment by Application, the Dermatophytic Onychomycosis market is segmented into
Hospitals
Clinics and laboratories
Others
Regional and Country-level Analysis
The Dermatophytic Onychomycosis market is analysed and market size information is provided by regions (countries).
The key regions covered in the Dermatophytic Onychomycosis market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dermatophytic Onychomycosis Market Share Analysis
Dermatophytic Onychomycosis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dermatophytic Onychomycosis business, the date to enter into the Dermatophytic Onychomycosis market, Dermatophytic Onychomycosis product introduction, recent developments, etc.
The major vendors covered:
Anacor Pharmaceuticals
Galderma
Janssen Biotech
Novartis
Bausch Health
Abeona Therapeutics
Allergan
Elorac
GlaxoSmithKline
Hexima
Hisamitsu Pharmaceutical
Mayne Pharma
MediQuest Therapeutics
Meiji Seika Pharma
Merz Pharma
Moberg Pharma
NanoBio
NovaBiotics
Nuvo Research
Pfizer
Polichem
Promius Pharma
Sanofi
Seren Pharmaceuticals
Taro Pharmaceutical
Topica Pharmaceuticals
Viamet Pharmaceuticals
1 Study Coverage
1.1 Dermatophytic Onychomycosis Product Introduction
1.2 Market Segments
1.3 Key Dermatophytic Onychomycosis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Dermatophytic Onychomycosis Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Topical
1.5 Market by Application
1.5.1 Global Dermatophytic Onychomycosis Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics and laboratories
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dermatophytic Onychomycosis Market Size, Estimates and Forecasts
2.1.1 Global Dermatophytic Onychomycosis Revenue 2015-2026
2.1.2 Global Dermatophytic Onychomycosis Sales 2015-2026
2.2 Global Dermatophytic Onychomycosis, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Dermatophytic Onychomycosis Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Dermatophytic Onychomycosis Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Dermatophytic Onychomycosis Competitor Landscape by Players
3.1 Dermatophytic Onychomycosis Sales by Manufacturers
3.1.1 Dermatophytic Onychomycosis Sales by Manufacturers (2015-2020)
3.1.2 Dermatophytic Onychomycosis Sales Market Share by Manufacturers (2015-2020)
3.2 Dermatophytic Onychomycosis Revenue by Manufacturers
3.2.1 Dermatophytic Onychomycosis Revenue by Manufacturers (2015-2020)
3.2.2 Dermatophytic Onychomycosis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Dermatophytic Onychomycosis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Dermatophytic Onychomycosis Revenue in 2019
3.2.5 Global Dermatophytic Onychomycosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Dermatophytic Onychomycosis Price by Manufacturers
3.4 Dermatophytic Onychomycosis Manufacturing Base Distribution, Product Types
3.4.1 Dermatophytic Onychomycosis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dermatophytic Onychomycosis Product Type
3.4.3 Date of International Manufacturers Enter into Dermatophytic Onychomycosis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dermatophytic Onychomycosis Market Size by Type (2015-2020)
4.1.1 Global Dermatophytic Onychomycosis Sales by Type (2015-2020)
4.1.2 Global Dermatophytic Onychomycosis Revenue by Type (2015-2020)
4.1.3 Dermatophytic Onychomycosis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Dermatophytic Onychomycosis Market Size Forecast by Type (2021-2026)
4.2.1 Global Dermatophytic Onychomycosis Sales Forecast by Type (2021-2026)
4.2.2 Global Dermatophytic Onychomycosis Revenue Forecast by Type (2021-2026)
4.2.3 Dermatophytic Onychomycosis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Dermatophytic Onychomycosis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Dermatophytic Onychomycosis Market Size by Application (2015-2020)
5.1.1 Global Dermatophytic Onychomycosis Sales by Application (2015-2020)
5.1.2 Global Dermatophytic Onychomycosis Revenue by Application (2015-2020)
5.1.3 Dermatophytic Onychomycosis Price by Application (2015-2020)
5.2 Dermatophytic Onychomycosis Market Size Forecast by Application (2021-2026)
5.2.1 Global Dermatophytic Onychomycosis Sales Forecast by Application (2021-2026)
5.2.2 Global Dermatophytic Onychomycosis Revenue Forecast by Application (2021-2026)
5.2.3 Global Dermatophytic Onychomycosis Price Forecast by Application (2021-2026)
6 North America
6.1 North America Dermatophytic Onychomycosis by Country
6.1.1 North America Dermatophytic Onychomycosis Sales by Country
6.1.2 North America Dermatophytic Onychomycosis Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Dermatophytic Onychomycosis Market Facts & Figures by Type
6.3 North America Dermatophytic Onychomycosis Market Facts & Figures by Application
7 Europe
7.1 Europe Dermatophytic Onychomycosis by Country
7.1.1 Europe Dermatophytic Onychomycosis Sales by Country
7.1.2 Europe Dermatophytic Onychomycosis Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dermatophytic Onychomycosis Market Facts & Figures by Type
7.3 Europe Dermatophytic Onychomycosis Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Dermatophytic Onychomycosis by Region
8.1.1 Asia Pacific Dermatophytic Onychomycosis Sales by Region
8.1.2 Asia Pacific Dermatophytic Onychomycosis Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Dermatophytic Onychomycosis Market Facts & Figures by Type
8.3 Asia Pacific Dermatophytic Onychomycosis Market Facts & Figures by Application
9 Latin America
9.1 Latin America Dermatophytic Onychomycosis by Country
9.1.1 Latin America Dermatophytic Onychomycosis Sales by Country
9.1.2 Latin America Dermatophytic Onychomycosis Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Dermatophytic Onychomycosis Market Facts & Figures by Type
9.3 Central & South America Dermatophytic Onychomycosis Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Dermatophytic Onychomycosis by Country
10.1.1 Middle East and Africa Dermatophytic Onychomycosis Sales by Country
10.1.2 Middle East and Africa Dermatophytic Onychomycosis Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Dermatophytic Onychomycosis Market Facts & Figures by Type
10.3 Middle East and Africa Dermatophytic Onychomycosis Market Facts & Figures by Application
11 Company Profiles
11.1 Anacor Pharmaceuticals
11.1.1 Anacor Pharmaceuticals Corporation Information
11.1.2 Anacor Pharmaceuticals Description and Business Overview
11.1.3 Anacor Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Anacor Pharmaceuticals Dermatophytic Onychomycosis Products Offered
11.1.5 Anacor Pharmaceuticals Related Developments
11.2 Galderma
11.2.1 Galderma Corporation Information
11.2.2 Galderma Description and Business Overview
11.2.3 Galderma Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Galderma Dermatophytic Onychomycosis Products Offered
11.2.5 Galderma Related Developments
11.3 Janssen Biotech
11.3.1 Janssen Biotech Corporation Information
11.3.2 Janssen Biotech Description and Business Overview
11.3.3 Janssen Biotech Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Janssen Biotech Dermatophytic Onychomycosis Products Offered
11.3.5 Janssen Biotech Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Dermatophytic Onychomycosis Products Offered
11.4.5 Novartis Related Developments
11.5 Bausch Health
11.5.1 Bausch Health Corporation Information
11.5.2 Bausch Health Description and Business Overview
11.5.3 Bausch Health Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bausch Health Dermatophytic Onychomycosis Products Offered
11.5.5 Bausch Health Related Developments
11.6 Abeona Therapeutics
11.6.1 Abeona Therapeutics Corporation Information
11.6.2 Abeona Therapeutics Description and Business Overview
11.6.3 Abeona Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Abeona Therapeutics Dermatophytic Onychomycosis Products Offered
11.6.5 Abeona Therapeutics Related Developments
11.7 Allergan
11.7.1 Allergan Corporation Information
11.7.2 Allergan Description and Business Overview
11.7.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Allergan Dermatophytic Onychomycosis Products Offered
11.7.5 Allergan Related Developments
11.8 Elorac
11.8.1 Elorac Corporation Information
11.8.2 Elorac Description and Business Overview
11.8.3 Elorac Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Elorac Dermatophytic Onychomycosis Products Offered
11.8.5 Elorac Related Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Description and Business Overview
11.9.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GlaxoSmithKline Dermatophytic Onychomycosis Products Offered
11.9.5 GlaxoSmithKline Related Developments
11.10 Hexima
11.10.1 Hexima Corporation Information
11.10.2 Hexima Description and Business Overview
11.10.3 Hexima Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Hexima Dermatophytic Onychomycosis Products Offered
11.10.5 Hexima Related Developments
11.1 Anacor Pharmaceuticals
11.1.1 Anacor Pharmaceuticals Corporation Information
11.1.2 Anacor Pharmaceuticals Description and Business Overview
11.1.3 Anacor Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Anacor Pharmaceuticals Dermatophytic Onychomycosis Products Offered
11.1.5 Anacor Pharmaceuticals Related Developments
11.12 Mayne Pharma
11.12.1 Mayne Pharma Corporation Information
11.12.2 Mayne Pharma Description and Business Overview
11.12.3 Mayne Pharma Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Mayne Pharma Products Offered
11.12.5 Mayne Pharma Related Developments
11.13 MediQuest Therapeutics
11.13.1 MediQuest Therapeutics Corporation Information
11.13.2 MediQuest Therapeutics Description and Business Overview
11.13.3 MediQuest Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.13.4 MediQuest Therapeutics Products Offered
11.13.5 MediQuest Therapeutics Related Developments
11.14 Meiji Seika Pharma
11.14.1 Meiji Seika Pharma Corporation Information
11.14.2 Meiji Seika Pharma Description and Business Overview
11.14.3 Meiji Seika Pharma Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Meiji Seika Pharma Products Offered
11.14.5 Meiji Seika Pharma Related Developments
11.15 Merz Pharma
11.15.1 Merz Pharma Corporation Information
11.15.2 Merz Pharma Description and Business Overview
11.15.3 Merz Pharma Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Merz Pharma Products Offered
11.15.5 Merz Pharma Related Developments
11.16 Moberg Pharma
11.16.1 Moberg Pharma Corporation Information
11.16.2 Moberg Pharma Description and Business Overview
11.16.3 Moberg Pharma Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Moberg Pharma Products Offered
11.16.5 Moberg Pharma Related Developments
11.17 NanoBio
11.17.1 NanoBio Corporation Information
11.17.2 NanoBio Description and Business Overview
11.17.3 NanoBio Sales, Revenue and Gross Margin (2015-2020)
11.17.4 NanoBio Products Offered
11.17.5 NanoBio Related Developments
11.18 NovaBiotics
11.18.1 NovaBiotics Corporation Information
11.18.2 NovaBiotics Description and Business Overview
11.18.3 NovaBiotics Sales, Revenue and Gross Margin (2015-2020)
11.18.4 NovaBiotics Products Offered
11.18.5 NovaBiotics Related Developments
11.19 Nuvo Research
11.19.1 Nuvo Research Corporation Information
11.19.2 Nuvo Research Description and Business Overview
11.19.3 Nuvo Research Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Nuvo Research Products Offered
11.19.5 Nuvo Research Related Developments
11.20 Pfizer
11.20.1 Pfizer Corporation Information
11.20.2 Pfizer Description and Business Overview
11.20.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Pfizer Products Offered
11.20.5 Pfizer Related Developments
11.21 Polichem
11.21.1 Polichem Corporation Information
11.21.2 Polichem Description and Business Overview
11.21.3 Polichem Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Polichem Products Offered
11.21.5 Polichem Related Developments
11.22 Promius Pharma
11.22.1 Promius Pharma Corporation Information
11.22.2 Promius Pharma Description and Business Overview
11.22.3 Promius Pharma Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Promius Pharma Products Offered
11.22.5 Promius Pharma Related Developments
11.23 Sanofi
11.23.1 Sanofi Corporation Information
11.23.2 Sanofi Description and Business Overview
11.23.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.23.4 Sanofi Products Offered
11.23.5 Sanofi Related Developments
11.24 Seren Pharmaceuticals
11.24.1 Seren Pharmaceuticals Corporation Information
11.24.2 Seren Pharmaceuticals Description and Business Overview
11.24.3 Seren Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.24.4 Seren Pharmaceuticals Products Offered
11.24.5 Seren Pharmaceuticals Related Developments
11.25 Taro Pharmaceutical
11.25.1 Taro Pharmaceutical Corporation Information
11.25.2 Taro Pharmaceutical Description and Business Overview
11.25.3 Taro Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.25.4 Taro Pharmaceutical Products Offered
11.25.5 Taro Pharmaceutical Related Developments
11.26 Topica Pharmaceuticals
11.26.1 Topica Pharmaceuticals Corporation Information
11.26.2 Topica Pharmaceuticals Description and Business Overview
11.26.3 Topica Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.26.4 Topica Pharmaceuticals Products Offered
11.26.5 Topica Pharmaceuticals Related Developments
11.27 Viamet Pharmaceuticals
11.27.1 Viamet Pharmaceuticals Corporation Information
11.27.2 Viamet Pharmaceuticals Description and Business Overview
11.27.3 Viamet Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.27.4 Viamet Pharmaceuticals Products Offered
11.27.5 Viamet Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Dermatophytic Onychomycosis Market Estimates and Projections by Region
12.1.1 Global Dermatophytic Onychomycosis Sales Forecast by Regions 2021-2026
12.1.2 Global Dermatophytic Onychomycosis Revenue Forecast by Regions 2021-2026
12.2 North America Dermatophytic Onychomycosis Market Size Forecast (2021-2026)
12.2.1 North America: Dermatophytic Onychomycosis Sales Forecast (2021-2026)
12.2.2 North America: Dermatophytic Onychomycosis Revenue Forecast (2021-2026)
12.2.3 North America: Dermatophytic Onychomycosis Market Size Forecast by Country (2021-2026)
12.3 Europe Dermatophytic Onychomycosis Market Size Forecast (2021-2026)
12.3.1 Europe: Dermatophytic Onychomycosis Sales Forecast (2021-2026)
12.3.2 Europe: Dermatophytic Onychomycosis Revenue Forecast (2021-2026)
12.3.3 Europe: Dermatophytic Onychomycosis Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Dermatophytic Onychomycosis Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Dermatophytic Onychomycosis Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Dermatophytic Onychomycosis Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Dermatophytic Onychomycosis Market Size Forecast by Region (2021-2026)
12.5 Latin America Dermatophytic Onychomycosis Market Size Forecast (2021-2026)
12.5.1 Latin America: Dermatophytic Onychomycosis Sales Forecast (2021-2026)
12.5.2 Latin America: Dermatophytic Onychomycosis Revenue Forecast (2021-2026)
12.5.3 Latin America: Dermatophytic Onychomycosis Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Dermatophytic Onychomycosis Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Dermatophytic Onychomycosis Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Dermatophytic Onychomycosis Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Dermatophytic Onychomycosis Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Dermatophytic Onychomycosis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dermatophytic Onychomycosis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Dermatophytic Onychomycosis Market Segments
Table 2. Ranking of Global Top Dermatophytic Onychomycosis Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Dermatophytic Onychomycosis Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Topical
Table 6. Global Dermatophytic Onychomycosis Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Dermatophytic Onychomycosis Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Dermatophytic Onychomycosis Sales by Regions 2015-2020 (K Units)
Table 9. Global Dermatophytic Onychomycosis Sales Market Share by Regions (2015-2020)
Table 10. Global Dermatophytic Onychomycosis Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Dermatophytic Onychomycosis Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Dermatophytic Onychomycosis Sales Share by Manufacturers (2015-2020)
Table 13. Global Dermatophytic Onychomycosis Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Dermatophytic Onychomycosis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatophytic Onychomycosis as of 2019)
Table 15. Dermatophytic Onychomycosis Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Dermatophytic Onychomycosis Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Dermatophytic Onychomycosis Price (2015-2020) (USD/Unit)
Table 18. Dermatophytic Onychomycosis Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Dermatophytic Onychomycosis Product Type
Table 20. Date of International Manufacturers Enter into Dermatophytic Onychomycosis Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Dermatophytic Onychomycosis Sales by Type (2015-2020) (K Units)
Table 23. Global Dermatophytic Onychomycosis Sales Share by Type (2015-2020)
Table 24. Global Dermatophytic Onychomycosis Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Dermatophytic Onychomycosis Revenue Share by Type (2015-2020)
Table 26. Dermatophytic Onychomycosis Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Dermatophytic Onychomycosis Sales by Application (2015-2020) (K Units)
Table 28. Global Dermatophytic Onychomycosis Sales Share by Application (2015-2020)
Table 29. North America Dermatophytic Onychomycosis Sales by Country (2015-2020) (K Units)
Table 30. North America Dermatophytic Onychomycosis Sales Market Share by Country (2015-2020)
Table 31. North America Dermatophytic Onychomycosis Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Dermatophytic Onychomycosis Revenue Market Share by Country (2015-2020)
Table 33. North America Dermatophytic Onychomycosis Sales by Type (2015-2020) (K Units)
Table 34. North America Dermatophytic Onychomycosis Sales Market Share by Type (2015-2020)
Table 35. North America Dermatophytic Onychomycosis Sales by Application (2015-2020) (K Units)
Table 36. North America Dermatophytic Onychomycosis Sales Market Share by Application (2015-2020)
Table 37. Europe Dermatophytic Onychomycosis Sales by Country (2015-2020) (K Units)
Table 38. Europe Dermatophytic Onychomycosis Sales Market Share by Country (2015-2020)
Table 39. Europe Dermatophytic Onychomycosis Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Dermatophytic Onychomycosis Revenue Market Share by Country (2015-2020)
Table 41. Europe Dermatophytic Onychomycosis Sales by Type (2015-2020) (K Units)
Table 42. Europe Dermatophytic Onychomycosis Sales Market Share by Type (2015-2020)
Table 43. Europe Dermatophytic Onychomycosis Sales by Application (2015-2020) (K Units)
Table 44. Europe Dermatophytic Onychomycosis Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Dermatophytic Onychomycosis Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Dermatophytic Onychomycosis Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Dermatophytic Onychomycosis Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Dermatophytic Onychomycosis Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Dermatophytic Onychomycosis Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Dermatophytic Onychomycosis Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Dermatophytic Onychomycosis Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Dermatophytic Onychomycosis Sales Market Share by Application (2015-2020)
Table 53. Latin America Dermatophytic Onychomycosis Sales by Country (2015-2020) (K Units)
Table 54. Latin America Dermatophytic Onychomycosis Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Dermatophytic Onychomycosis Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Dermatophytic Onychomycosis Revenue Market Share by Country (2015-2020)
Table 57. Latin America Dermatophytic Onychomycosis Sales by Type (2015-2020) (K Units)
Table 58. Latin America Dermatophytic Onychomycosis Sales Market Share by Type (2015-2020)
Table 59. Latin America Dermatophytic Onychomycosis Sales by Application (2015-2020) (K Units)
Table 60. Latin America Dermatophytic Onychomycosis Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Dermatophytic Onychomycosis Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Dermatophytic Onychomycosis Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Dermatophytic Onychomycosis Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Dermatophytic Onychomycosis Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Dermatophytic Onychomycosis Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Dermatophytic Onychomycosis Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Dermatophytic Onychomycosis Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Dermatophytic Onychomycosis Sales Market Share by Application (2015-2020)
Table 69. Anacor Pharmaceuticals Corporation Information
Table 70. Anacor Pharmaceuticals Description and Major Businesses
Table 71. Anacor Pharmaceuticals Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Anacor Pharmaceuticals Product
Table 73. Anacor Pharmaceuticals Recent Development
Table 74. Galderma Corporation Information
Table 75. Galderma Description and Major Businesses
Table 76. Galderma Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Galderma Product
Table 78. Galderma Recent Development
Table 79. Janssen Biotech Corporation Information
Table 80. Janssen Biotech Description and Major Businesses
Table 81. Janssen Biotech Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Janssen Biotech Product
Table 83. Janssen Biotech Recent Development
Table 84. Novartis Corporation Information
Table 85. Novartis Description and Major Businesses
Table 86. Novartis Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Novartis Product
Table 88. Novartis Recent Development
Table 89. Bausch Health Corporation Information
Table 90. Bausch Health Description and Major Businesses
Table 91. Bausch Health Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Bausch Health Product
Table 93. Bausch Health Recent Development
Table 94. Abeona Therapeutics Corporation Information
Table 95. Abeona Therapeutics Description and Major Businesses
Table 96. Abeona Therapeutics Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Abeona Therapeutics Product
Table 98. Abeona Therapeutics Recent Development
Table 99. Allergan Corporation Information
Table 100. Allergan Description and Major Businesses
Table 101. Allergan Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Allergan Product
Table 103. Allergan Recent Development
Table 104. Elorac Corporation Information
Table 105. Elorac Description and Major Businesses
Table 106. Elorac Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Elorac Product
Table 108. Elorac Recent Development
Table 109. GlaxoSmithKline Corporation Information
Table 110. GlaxoSmithKline Description and Major Businesses
Table 111. GlaxoSmithKline Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. GlaxoSmithKline Product
Table 113. GlaxoSmithKline Recent Development
Table 114. Hexima Corporation Information
Table 115. Hexima Description and Major Businesses
Table 116. Hexima Dermatophytic Onychomycosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Hexima Product
Table 118. Hexima Recent Development
Table 119. Hisamitsu Pharmaceutical Corporation Information
Table 120. Hisamitsu Pharmaceutical Description and Major Businesses
Table 121. Hisamitsu Pharmaceutical Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Hisamitsu Pharmaceutical Product
Table 123. Hisamitsu Pharmaceutical Recent Development
Table 124. Mayne Pharma Corporation Information
Table 125. Mayne Pharma Description and Major Businesses
Table 126. Mayne Pharma Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Mayne Pharma Product
Table 128. Mayne Pharma Recent Development
Table 129. MediQuest Therapeutics Corporation Information
Table 130. MediQuest Therapeutics Description and Major Businesses
Table 131. MediQuest Therapeutics Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. MediQuest Therapeutics Product
Table 133. MediQuest Therapeutics Recent Development
Table 134. Meiji Seika Pharma Corporation Information
Table 135. Meiji Seika Pharma Description and Major Businesses
Table 136. Meiji Seika Pharma Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Meiji Seika Pharma Product
Table 138. Meiji Seika Pharma Recent Development
Table 139. Merz Pharma Corporation Information
Table 140. Merz Pharma Description and Major Businesses
Table 141. Merz Pharma Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Merz Pharma Product
Table 143. Merz Pharma Recent Development
Table 144. Moberg Pharma Corporation Information
Table 145. Moberg Pharma Description and Major Businesses
Table 146. Moberg Pharma Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. Moberg Pharma Product
Table 148. Moberg Pharma Recent Development
Table 149. NanoBio Corporation Information
Table 150. NanoBio Description and Major Businesses
Table 151. NanoBio Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. NanoBio Product
Table 153. NanoBio Recent Development
Table 154. NovaBiotics Corporation Information
Table 155. NovaBiotics Description and Major Businesses
Table 156. NovaBiotics Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. NovaBiotics Product
Table 158. NovaBiotics Recent Development
Table 159. Nuvo Research Corporation Information
Table 160. Nuvo Research Description and Major Businesses
Table 161. Nuvo Research Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Nuvo Research Product
Table 163. Nuvo Research Recent Development
Table 164. Pfizer Corporation Information
Table 165. Pfizer Description and Major Businesses
Table 166. Pfizer Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 167. Pfizer Product
Table 168. Pfizer Recent Development
Table 169. Polichem Corporation Information
Table 170. Polichem Description and Major Businesses
Table 171. Polichem Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 172. Polichem Product
Table 173. Polichem Recent Development
Table 174. Promius Pharma Corporation Information
Table 175. Promius Pharma Description and Major Businesses
Table 176. Promius Pharma Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 177. Promius Pharma Product
Table 178. Promius Pharma Recent Development
Table 179. Sanofi Corporation Information
Table 180. Sanofi Description and Major Businesses
Table 181. Sanofi Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 182. Sanofi Product
Table 183. Sanofi Recent Development
Table 184. Seren Pharmaceuticals Corporation Information
Table 185. Seren Pharmaceuticals Description and Major Businesses
Table 186. Seren Pharmaceuticals Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 187. Seren Pharmaceuticals Product
Table 188. Seren Pharmaceuticals Recent Development
Table 189. Taro Pharmaceutical Corporation Information
Table 190. Taro Pharmaceutical Description and Major Businesses
Table 191. Taro Pharmaceutical Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 192. Taro Pharmaceutical Product
Table 193. Taro Pharmaceutical Recent Development
Table 194. Topica Pharmaceuticals Corporation Information
Table 195. Topica Pharmaceuticals Description and Major Businesses
Table 196. Topica Pharmaceuticals Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 197. Topica Pharmaceuticals Product
Table 198. Topica Pharmaceuticals Recent Development
Table 199. Viamet Pharmaceuticals Corporation Information
Table 200. Viamet Pharmaceuticals Description and Major Businesses
Table 201. Viamet Pharmaceuticals Dermatophytic Onychomycosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 202. Viamet Pharmaceuticals Product
Table 203. Viamet Pharmaceuticals Recent Development
Table 204. Global Dermatophytic Onychomycosis Sales Forecast by Regions (2021-2026) (K Units)
Table 205. Global Dermatophytic Onychomycosis Sales Market Share Forecast by Regions (2021-2026)
Table 206. Global Dermatophytic Onychomycosis Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 207. Global Dermatophytic Onychomycosis Revenue Market Share Forecast by Regions (2021-2026)
Table 208. North America: Dermatophytic Onychomycosis Sales Forecast by Country (2021-2026) (K Units)
Table 209. North America: Dermatophytic Onychomycosis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 210. Europe: Dermatophytic Onychomycosis Sales Forecast by Country (2021-2026) (K Units)
Table 211. Europe: Dermatophytic Onychomycosis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 212. Asia Pacific: Dermatophytic Onychomycosis Sales Forecast by Region (2021-2026) (K Units)
Table 213. Asia Pacific: Dermatophytic Onychomycosis Revenue Forecast by Region (2021-2026) (US$ Million)
Table 214. Latin America: Dermatophytic Onychomycosis Sales Forecast by Country (2021-2026) (K Units)
Table 215. Latin America: Dermatophytic Onychomycosis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 216. Middle East and Africa: Dermatophytic Onychomycosis Sales Forecast by Country (2021-2026) (K Units)
Table 217. Middle East and Africa: Dermatophytic Onychomycosis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 218. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 219. Key Challenges
Table 220. Market Risks
Table 221. Main Points Interviewed from Key Dermatophytic Onychomycosis Players
Table 222. Dermatophytic Onychomycosis Customers List
Table 223. Dermatophytic Onychomycosis Distributors List
Table 224. Research Programs/Design for This Report
Table 225. Key Data Information from Secondary Sources
Table 226. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatophytic Onychomycosis Product Picture
Figure 2. Global Dermatophytic Onychomycosis Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Topical Product Picture
Figure 5. Global Dermatophytic Onychomycosis Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Clinics and laboratories
Figure 8. Others
Figure 9. Dermatophytic Onychomycosis Report Years Considered
Figure 10. Global Dermatophytic Onychomycosis Market Size 2015-2026 (US$ Million)
Figure 11. Global Dermatophytic Onychomycosis Sales 2015-2026 (K Units)
Figure 12. Global Dermatophytic Onychomycosis Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Dermatophytic Onychomycosis Sales Market Share by Region (2015-2020)
Figure 14. Global Dermatophytic Onychomycosis Sales Market Share by Region in 2019
Figure 15. Global Dermatophytic Onychomycosis Revenue Market Share by Region (2015-2020)
Figure 16. Global Dermatophytic Onychomycosis Revenue Market Share by Region in 2019
Figure 17. Global Dermatophytic Onychomycosis Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Dermatophytic Onychomycosis Revenue in 2019
Figure 19. Dermatophytic Onychomycosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Dermatophytic Onychomycosis Sales Market Share by Type (2015-2020)
Figure 21. Global Dermatophytic Onychomycosis Sales Market Share by Type in 2019
Figure 22. Global Dermatophytic Onychomycosis Revenue Market Share by Type (2015-2020)
Figure 23. Global Dermatophytic Onychomycosis Revenue Market Share by Type in 2019
Figure 24. Global Dermatophytic Onychomycosis Market Share by Price Range (2015-2020)
Figure 25. Global Dermatophytic Onychomycosis Sales Market Share by Application (2015-2020)
Figure 26. Global Dermatophytic Onychomycosis Sales Market Share by Application in 2019
Figure 27. Global Dermatophytic Onychomycosis Revenue Market Share by Application (2015-2020)
Figure 28. Global Dermatophytic Onychomycosis Revenue Market Share by Application in 2019
Figure 29. North America Dermatophytic Onychomycosis Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Dermatophytic Onychomycosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Dermatophytic Onychomycosis Sales Market Share by Country in 2019
Figure 32. North America Dermatophytic Onychomycosis Revenue Market Share by Country in 2019
Figure 33. U.S. Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Dermatophytic Onychomycosis Market Share by Type in 2019
Figure 38. North America Dermatophytic Onychomycosis Market Share by Application in 2019
Figure 39. Europe Dermatophytic Onychomycosis Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Dermatophytic Onychomycosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Dermatophytic Onychomycosis Sales Market Share by Country in 2019
Figure 42. Europe Dermatophytic Onychomycosis Revenue Market Share by Country in 2019
Figure 43. Germany Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Dermatophytic Onychomycosis Market Share by Type in 2019
Figure 54. Europe Dermatophytic Onychomycosis Market Share by Application in 2019
Figure 55. Asia Pacific Dermatophytic Onychomycosis Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Dermatophytic Onychomycosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Dermatophytic Onychomycosis Sales Market Share by Region in 2019
Figure 58. Asia Pacific Dermatophytic Onychomycosis Revenue Market Share by Region in 2019
Figure 59. China Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Dermatophytic Onychomycosis Market Share by Type in 2019
Figure 82. Asia Pacific Dermatophytic Onychomycosis Market Share by Application in 2019
Figure 83. Latin America Dermatophytic Onychomycosis Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Dermatophytic Onychomycosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Dermatophytic Onychomycosis Sales Market Share by Country in 2019
Figure 86. Latin America Dermatophytic Onychomycosis Revenue Market Share by Country in 2019
Figure 87. Mexico Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Dermatophytic Onychomycosis Market Share by Type in 2019
Figure 94. Latin America Dermatophytic Onychomycosis Market Share by Application in 2019
Figure 95. Middle East and Africa Dermatophytic Onychomycosis Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Dermatophytic Onychomycosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Dermatophytic Onychomycosis Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Dermatophytic Onychomycosis Revenue Market Share by Country in 2019
Figure 99. Turkey Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Dermatophytic Onychomycosis Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Dermatophytic Onychomycosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Dermatophytic Onychomycosis Market Share by Type in 2019
Figure 106. Middle East and Africa Dermatophytic Onychomycosis Market Share by Application in 2019
Figure 107. North America Dermatophytic Onychomycosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Dermatophytic Onychomycosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Dermatophytic Onychomycosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Dermatophytic Onychomycosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Dermatophytic Onychomycosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Dermatophytic Onychomycosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Dermatophytic Onychomycosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Dermatophytic Onychomycosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Dermatophytic Onychomycosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Dermatophytic Onychomycosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
皮膚糸状菌性爪真菌症治療薬（DOT）の世界市場（～2026年） Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.…- 皮膚糸状菌性爪真菌症治療（DOT）の世界市場（～2026年） Dermatophytic onychomycosis, also known as tinea unguium, is a fungal disease of toenails or fingernails that causes ring infection over nails. Dermatophytic onychomycosis could be treated with either topical preparations or oral antifungal agents based on the severity of infection. The treatment of…
- 爪真菌症の世界市場（～2026年） Onychomycosis, also known as tinea unguium, is a fungal infection of the nail. Symptoms may include white or yellow nail discoloration, thickening of the nail, and separation of the nail from the nail bed. Toenails or fingernails may be affected, but it is more common for toenails to be affected. Co…
- 経口・局所麻酔薬の世界市場（～2026年） Oral & Topical Anesthetics penetrate mucosal surfaces of mouth more easily than through a keratinized surface because of the absence of a stratum corneum (through the openings of the hair follicles and sweat glands. Oral & Topical anesthetics are being widely used in anesthesia, dentistry, and aesth…
- 口腔カンジダ症の世界市場（～2026年） Oral thrush occurs when a yeast infection develops on the inside of mouth and on tongue. This condition is also known as oral candidiasis, oropharyngeal candidiasis, or, simply, thrush. The Candida albicans fungus causes oral thrush. A small amount of this fungus normally lives in your mouth without…